69 related articles for article (PubMed ID: 22689915)
1. Targeting FACT complex suppresses mammary tumorigenesis in Her2/neu transgenic mice.
Koman IE; Commane M; Paszkiewicz G; Hoonjan B; Pal S; Safina A; Toshkov I; Purmal AA; Wang D; Liu S; Morrison C; Gudkov AV; Gurova KV
Cancer Prev Res (Phila); 2012 Aug; 5(8):1025-35. PubMed ID: 22689915
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
3. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
4. Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA
Cancer Immunol Immunother; 2005 Jun; 54(6):599-610. PubMed ID: 15690207
[TBL] [Abstract][Full Text] [Related]
5. Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?
Calogero RA; Quaglino E; Saviozzi S; Forni G; Cavallo F
Cancer Immunol Immunother; 2008 Nov; 57(11):1685-94. PubMed ID: 18286283
[TBL] [Abstract][Full Text] [Related]
6. Herbal tonic does not inhibit estrogen receptor negative mammary tumor development in a transgenic mouse model.
Bennett LM; Montgomery JL; Collins NK; Steinberg SM; Kulp KS
J Complement Integr Med; 2011 Jan; 8():. PubMed ID: 22754942
[TBL] [Abstract][Full Text] [Related]
7. Chromatin as an old and new anticancer target.
Neefjes J; Gurova K; Sarthy J; Szabó G; Henikoff S
Trends Cancer; 2024 Jun; ():. PubMed ID: 38825423
[TBL] [Abstract][Full Text] [Related]
8. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.
Burkhart C; Fleyshman D; Kohrn R; Commane M; Garrigan J; Kurbatov V; Toshkov I; Ramachandran R; Martello L; Gurova KV
Oncotarget; 2014 Nov; 5(22):11038-53. PubMed ID: 25402820
[TBL] [Abstract][Full Text] [Related]
9. Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers.
Garcia H; Miecznikowski JC; Safina A; Commane M; Ruusulehto A; Kilpinen S; Leach RW; Attwood K; Li Y; Degan S; Omilian AR; Guryanova O; Papantonopoulou O; Wang J; Buck M; Liu S; Morrison C; Gurova KV
Cell Rep; 2013 Jul; 4(1):159-73. PubMed ID: 23831030
[TBL] [Abstract][Full Text] [Related]
10. Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancer.
Dermawan JK; Gurova K; Pink J; Dowlati A; De S; Narla G; Sharma N; Stark GR
Mol Cancer Ther; 2014 Sep; 13(9):2203-14. PubMed ID: 25028470
[TBL] [Abstract][Full Text] [Related]
11. Complex mutual regulation of facilitates chromatin transcription (FACT) subunits on both mRNA and protein levels in human cells.
Safina A; Garcia H; Commane M; Guryanova O; Degan S; Kolesnikova K; Gurova KV
Cell Cycle; 2013 Aug; 12(15):2423-34. PubMed ID: 23839038
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cell response to chromatin and DNA damage.
Luzhin A; Rajan P; Safina A; Leonova K; Stablewski A; Wang J; Robinson D; Isaeva N; Kantidze O; Gurova K
Nucleic Acids Res; 2023 Nov; 51(21):11836-11855. PubMed ID: 37855682
[TBL] [Abstract][Full Text] [Related]
13. Human FACT subunits coordinate to catalyze both disassembly and reassembly of nucleosomes.
McCauley MJ; Morse M; Becker N; Hu Q; Botuyan MV; Navarrete E; Huo R; Muthurajan UM; Rouzina I; Luger K; Mer G; Maher LJ; Williams MC
Cell Rep; 2022 Dec; 41(13):111858. PubMed ID: 36577379
[TBL] [Abstract][Full Text] [Related]
14. The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead.
Jia S; Guo B; Wang L; Peng L; Zhang L
J Healthc Eng; 2022; 2022():3528786. PubMed ID: 35463672
[TBL] [Abstract][Full Text] [Related]
15. SSRP1 affects the growth and apoptosis of gastric cancer cells through AKT pathway.
Jin G; Zhao R; Zhang J; Cao T; Tang T
J Med Biochem; 2022 Feb; 41(1):100-107. PubMed ID: 35291495
[TBL] [Abstract][Full Text] [Related]
16. The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3.
Jeong E; Martina JA; Contreras PS; Lee J; Puertollano R
Autophagy; 2022 Oct; 18(10):2333-2349. PubMed ID: 35230915
[TBL] [Abstract][Full Text] [Related]
17. SSRP1 Is a Prognostic Biomarker Correlated with CD8
Luo G; Xu J; Xia Z; Liu S; Liu H; He K; Xiang G
Biomed Res Int; 2021; 2021():9409836. PubMed ID: 33688504
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal Regulation of Mammalian SPT16 in Controlling Transcription.
Kaja A; Adhikari A; Karmakar S; Zhang W; Rothschild G; Basu U; Batra SK; Davie JK; Bhaumik SR
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526453
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of Ty 16 promotes lung cancer malignancy and is negatively regulated by miR-1227-5p.
Yang L; Wang X; Jiao X; Tian B; Zhang M; Zhou C; Wang R; Chen H; Wang B; Li J; Liu J; Zhang G; Liu P
Cancer Sci; 2020 Nov; 111(11):4075-4087. PubMed ID: 32860308
[TBL] [Abstract][Full Text] [Related]
20. Unresolved Complexity in the Gene Regulatory Network Underlying EMT.
Lavin DP; Tiwari VK
Front Oncol; 2020; 10():554. PubMed ID: 32477926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
